Mr. Jerry L. Jost
President and CEO
Jost Chemical Co.
8150 Lackland Rd
Saint Louis , MO 63114
United StatesFEI 3001239108Issued Jul 18, 2022Division of Pharmaceutical Quality Operations III
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3001239108.
Violations0
Issue DateJul 18, 2022
Product TypeDrugs
StatusOpen
Letter Details
Firm
Jost Chemical Co.
Location
Mr. Jerry L. Jost
President and CEO
Jost Chemical Co.
8150 Lackland Rd
Saint Louis , MO 63114
United States
FEI Number
3001239108
Country
United States
Issue Date
July 18, 2022
Issuing Office
Division of Pharmaceutical Quality Operations III
Product Type
Drugs
Status
Open
Summary
Jost Chemical Co., an active pharmaceutical ingredient (API) manufacturer, was cited for significant current good manufacturing practice (CGMP) violations that rendered their APIs adulterated. FDA inspectors found that the company's quality unit failed to adequately investigate and resolve quality-related complaints and out-of-specification results, including a 2018 mold contamination incident in Potassium Sulfate lots where the company did not initiate a formal recall or sufficiently expand investigations to identify all potentially affected batches. The inspection, conducted January 10-21, 2022, revealed that the company's methods, facilities, and controls for manufacturing, processing, packing, and holding did not conform to required regulatory standards under the Federal Food, Drug, and Cosmetic Act.
Jost Chemical Co. FDA Warning Letter, July 18, 2022